Effects of clinically relevant MPL mutations in the transmembrane domain revealed at the atomic level through computational modeling.
BACKGROUND: Mutations in the thrombopoietin receptor (MPL) may activate relevant pathways and lead to chronic myeloproliferative neoplasms (MPNs). The mechanisms of MPL activation remain elusive because of a lack of experimental structures. Modern computational biology techniques were utilized to ex...
Main Authors: | Tai-Sung Lee, Hagop Kantarjian, Wanlong Ma, Chen-Hsiung Yeh, Francis Giles, Maher Albitar |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3157383?pdf=render |
Similar Items
-
JAK2 exon 14 deletion in patients with chronic myeloproliferative neoplasms.
by: Wanlong Ma, et al.
Published: (2010-01-01) -
Nonfamilial, MPL S505N-Mutated Essential Thrombocythaemia
by: Ruth Morrell, et al.
Published: (2013-01-01) -
MPL Y252H and MPL F126fs mutations in essential thrombocythemia: Case series and review of literature
by: Ahmed G. Elsayed, et al.
Published: (2019-03-01) -
MPL W515 L/K mutations in myeloproliferative neoplasms
by: Sohaila Eldeweny, et al.
Published: (2019-12-01) -
Two activating mutations of MPL in triple‐negative myeloproliferative neoplasms
by: Juan Xie, et al.
Published: (2019-09-01)